Detalhe da pesquisa
1.
Neoadjuvant cemiplimab and surgery for stage II-IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 study.
Lancet Oncol
; 24(11): 1196-1205, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37875144
2.
A Phase I dose-escalation study of afatinib combined with nintedanib in patients with advanced solid tumors.
Future Oncol
; 11(10): 1479-91, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25963426
3.
Primary intestinal-type adenocarcinoma of the oral tongue: Case report and review of histologic origin and oncologic management.
Head Neck
; 40(7): E68-E72, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29756292
4.
A phase I trial of intermittent high-dose gefitinib and fixed-dose docetaxel in patients with advanced solid tumors.
Cancer Chemother Pharmacol
; 59(4): 467-75, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-16896930
5.
Unusual Case of Papillary Thyroid Carcinoma with Choroidal Metastasis.
Thyroid
; 25(7): 860-4, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25872533
6.
Randomized Multicenter Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (DCF) Versus DCF Plus Growth Factor Support in Patients With Metastatic Gastric Adenocarcinoma: A Study of the US Gastric Cancer Consortium.
J Clin Oncol
; 33(33): 3874-9, 2015 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-26438119
7.
Immunoglobulin G4-related sclerosing disease of the paranasal sinus.
Head Neck
; 35(10): E321-4, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23047661
8.
Evaluation of romidepsin for clinical activity and radioactive iodine reuptake in radioactive iodine-refractory thyroid carcinoma.
Thyroid
; 23(5): 593-9, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23186033
9.
Residents' work hours.
Ann Intern Med
; 141(9): 741; author reply 742, 2004 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-15520442
10.
Double-blind, placebo-controlled, randomized trial of granulocyte-colony stimulating factor during postoperative radiotherapy for squamous head and neck cancer.
Cancer J
; 12(3): 182-8, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-16803675
11.
Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm.
J Clin Oncol
; 24(7): 1072-8, 2006 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16505426